Please wait while we open this resource.
K
Clinical reviews
ASSOCIATION BETWEEN MALIGNANT MITRAL VALVE PROLAPSE AND SUDDEN CARDIAC DEATH
JAMA Cardiology
PDF9 pages3.8 MB
Malignant mitral valve prolapse (MVP) presents a heterogeneous clinical spectrum, with some patients facing a benign course while others are at risk for sudden cardiac death (SCD). The review highlights key electrocardiographic markers and morphofunctional characteristics that can help in identifying high-risk patients. It emphasizes the importance of early identification of complex arrhythmias that may occur before macrofibrosis is detectable. The findings suggest that newer imaging techniques may provide additional insights into the risk stratification of patients with MVP.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology